BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32673830)

  • 1. Accelerated treatment of endocarditis-The POET II trial: Rationale and design of a randomized controlled trial.
    Østergaard L; Pries-Heje MM; Hasselbalch RB; Rasmussen M; Åkesson P; Horvath R; Povlsen J; Gill S; Bruun NE; Müllertz K; Tuxen CD; Ihlemann N; Helweg-Larsen J; Moser C; Fosbøl EL; Bundgaard H; Iversen K
    Am Heart J; 2020 Sep; 227():40-46. PubMed ID: 32673830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study.
    Pries-Heje MM; Hjulmand JG; Lenz IT; Hasselbalch RB; Povlsen JA; Ihlemann N; Køber N; Tofterup ML; Østergaard L; Dalsgaard M; Faurholt-Jepsen D; Wienberg M; Christiansen U; Bruun NE; Fosbøl E; Moser C; Iversen KK; Bundgaard H
    Eur Heart J; 2023 Dec; 44(48):5095-5106. PubMed ID: 37879115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course antibiotic regimen compared to conventional antibiotic treatment for gram-positive cocci infective endocarditis: randomized clinical trial (SATIE).
    Olmos C; Vilacosta I; López J; Sáez C; Anguita M; García-Granja PE; Sarriá C; Silva J; Álvarez-Álvarez B; Martínez-Monzonis MA; Castillo JC; Seijas J; López-Picado A; Peral V; Maroto L; San Román JA
    BMC Infect Dis; 2020 Jun; 20(1):417. PubMed ID: 32546269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
    Cervera C; del Río A; García L; Sala M; Almela M; Moreno A; Falces C; Mestres CA; Marco F; Robau M; Gatell JM; Miró JM;
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):587-92. PubMed ID: 21723004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral switch versus standard intravenous antibiotic therapy in left-sided endocarditis due to susceptible staphylococci, streptococci or enterococci (RODEO): a protocol for two open-label randomised controlled trials.
    Lemaignen A; Bernard L; Tattevin P; Bru JP; Duval X; Hoen B; Brunet-Houdard S; Mainardi JL; Caille A;
    BMJ Open; 2020 Jul; 10(7):e033540. PubMed ID: 32665381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis.
    Iversen K; Ihlemann N; Gill SU; Madsen T; Elming H; Jensen KT; Bruun NE; Høfsten DE; Fursted K; Christensen JJ; Schultz M; Klein CF; Fosbøll EL; Rosenvinge F; Schønheyder HC; Køber L; Torp-Pedersen C; Helweg-Larsen J; Tønder N; Moser C; Bundgaard H
    N Engl J Med; 2019 Jan; 380(5):415-424. PubMed ID: 30152252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
    Trials; 2019 May; 20(1):250. PubMed ID: 31046810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial.
    Turner NA; Zaharoff S; King H; Evans S; Hamasaki T; Lodise T; Ghazaryan V; Beresnev T; Riccobene T; Patel R; Doernberg SB; Rappo U; Fowler VG; Holland TL;
    Trials; 2022 May; 23(1):407. PubMed ID: 35578360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimisation of the antibiotic guidelines in The Netherlands. VII. SWAB guidelines for antimicrobial therapy in adult patients with infectious endocarditis.
    Verhagen DW; van der Feltz M; Plokker HW; Buiting AG; Tjoeng MM; van der Meer JT;
    Neth J Med; 2003 Dec; 61(12):421-9. PubMed ID: 15025420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of embolization after institution of antibiotic therapy for infective endocarditis.
    Vilacosta I; Graupner C; San Román JA; Sarriá C; Ronderos R; Fernández C; Mancini L; Sanz O; Sanmartín JV; Stoermann W
    J Am Coll Cardiol; 2002 May; 39(9):1489-95. PubMed ID: 11985912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of bacterial endocarditis].
    Halawa B
    Wiad Lek; 1982 Nov; 35(19-20):1257-64. PubMed ID: 6819721
    [No Abstract]   [Full Text] [Related]  

  • 12. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
    Gil-Navarro MV; Lopez-Cortes LE; Luque-Marquez R; Galvez-Acebal J; de Alarcon-Gonzalez A
    J Clin Pharm Ther; 2018 Apr; 43(2):220-223. PubMed ID: 29030859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study.
    Østergaard L; Bruun NE; Voldstedlund M; Arpi M; Andersen CØ; Schønheyder HC; Lemming L; Rosenvinge F; Valeur N; Søgaard P; Andersen PS; Skov R; Chen M; Iversen K; Gill S; Lauridsen TK; Dahl A; Oestergaard LB; Povlsen JA; Moser C; Bundgaard H; Køber L; Fosbøl EL
    Eur Heart J; 2019 Oct; 40(39):3237-3244. PubMed ID: 31145782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles.
    Anguera I; Del Río A; Miró JM; Matínez-Lacasa X; Marco F; Gumá JR; Quaglio G; Claramonte X; Moreno A; Mestres CA; Mauri E; Azqueta M; Benito N; García-de la María C; Almela M; Jiménez-Expósito MJ; Sued O; De Lazzari E; Gatell JM;
    Heart; 2005 Feb; 91(2):e10. PubMed ID: 15657200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis.
    López J; Sevilla T; Vilacosta I; Sarriá C; Revilla A; Ortiz C; Ferrera C; Olmos C; Gómez I; San Román JA
    Eur Heart J; 2013 Jun; 34(23):1749-54. PubMed ID: 23144047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infective endocarditis in patients receiving long-term hemodialysis.
    McCarthy JT; Steckelberg JM
    Mayo Clin Proc; 2000 Oct; 75(10):1008-14. PubMed ID: 11040848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of bacterial endocarditis 1976.
    Benn R
    Drugs; 1976 Nov; 12(5):374-80. PubMed ID: 824117
    [No Abstract]   [Full Text] [Related]  

  • 18. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
    Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC
    Trials; 2018 May; 19(1):297. PubMed ID: 29843781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis.
    Carugati M; Bayer AS; Miró JM; Park LP; Guimarães AC; Skoutelis A; Fortes CQ; Durante-Mangoni E; Hannan MM; Nacinovich F; Fernández-Hidalgo N; Grossi P; Tan RS; Holland T; Fowler VG; Corey RG; Chu VH;
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6213-22. PubMed ID: 24080644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
    Scheld WM; Keeley JM
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():65-78. PubMed ID: 6421794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.